Document is current
Any future updates will be listed below
-
Authors
Shen, Mengjie
Ren, Huaying
Chen, Ting
Chen, Ke
-
Funding
Funding for this research was provided by:
Research and development of AI assessment technology for human embryo quality in in vitro and quality evaluation (No. CSTB2022TIAD-KPX0146)
Research and development of AI assessment technology for human embryo quality in in vitro and quality evaluation (No. CSTB2022TIAD-KPX0146)
Research and development of AI assessment technology for human embryo quality in in vitro and quality evaluation (No. CSTB2022TIAD-KPX0146)
Research and development of AI assessment technology for human embryo quality in in vitro and quality evaluation (No. CSTB2022TIAD-KPX0146)
Research and application of AI assessment technology for human oocyte and embryo quality in in vitro fertilization (82371728)
Research and application of AI assessment technology for human oocyte and embryo quality in in vitro fertilization (82371728)
Research and application of AI assessment technology for human oocyte and embryo quality in in vitro fertilization (82371728)
Research and application of AI assessment technology for human oocyte and embryo quality in in vitro fertilization (82371728)
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 12 April 2026
First Online: 28 April 2026
Declarations
:
: This study was approved by the Clinical Application and Ethics Committee of Human Assisted Reproductive Technology of Chongqing Health Center for Women and Children (2019-RGI-602) and was conducted with the informed consent of the patient’s parents.
: The authors declare no competing interests.
